Fulgent Genetics (FLGT) Enterprise Value (2016 - 2026)

Fulgent Genetics has disclosed Enterprise Value across 11 years of filings, most recently posting $301.9 million for Q2 2026.

• In Q2 2026, Enterprise Value fell 2.79% year-over-year to $301.9 million; the TTM figure through Jun 2026 stood at $301.9 million (down 2.79% YoY), while the FY2025 annual figure was $475.1 million, up 54.54% from the prior year.
• Enterprise Value came in at $301.9 million for Q2 2026 at Fulgent Genetics, up from $176.8 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $1.3 billion in Q1 2022 to a low of $176.8 million in Q1 2026.
• Average Enterprise Value over 5 years is $464.9 million, with a median of $346.6 million recorded in 2022.
• Year-over-year, Enterprise Value plunged 86.35% in 2022 and surged 54.54% in 2025.
• Over 5 years, Enterprise Value stood at $353.6 million in 2022, then gained by 21.68% to $430.3 million in 2023, then slipped by 28.55% to $307.5 million in 2024, then surged by 54.54% to $475.1 million in 2025, then sank by 36.45% to $301.9 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $301.9 million in Q2 2026, $176.8 million in Q1 2026, and $475.1 million in Q4 2025.